p27(Kip1)and p21(Cip1) are cyclin dependent kinase inhibitors which can arr
est cell proliferation and p27 is a tumor suppressor gene. To address the m
echanism of tumor suppression by p27 and to determine if p21 has a tumor su
ppressor phenotype, we utilized the two stage skin carcinogenesis model on
p27 and p21 knockout mice. In this model, initiation, which involves mutati
on of H-ras induced by DMBA, can be distinguished from promotion induced by
TPA, and progression to carcinoma. The mean number of papillomas did not d
iffer between p27 - / - and control littermates, but papilloma growth rate
was increased and carcinomas developed earlier. Thus, p27 deficiency did no
t enhance initiation, but resulted in more rapid clonal expansion of initia
ted cells during promotion. TPA treatment reduced p27 expression in keratin
ocytes also supporting a role for p27 during promotion. Tumors from p27 - /
- mice contained mutant H-ras indicating that p27 deficiency did not subst
itute for mutant ras and further, that during ras driven tumor growth, p27
is partially antagonistic since its removal led to faster growth. The treat
ed p27 - / - mice also developed intestinal adenomas, p21 - / - mice did no
t display a significant increase in tumor numbers, growth rate or progressi
on to carcinomas and these tumors also had mutated H-rns. Carcinomas from p
21 - / - mice were more poorly differentiated with a high frequency of anap
lastic spindle cell carcinomas. Thus p21 deficiency mainly resulted in high
er grade undifferentiated tumors.